These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans. Early and late manifestations of Ixodes ricinus-borne Borrelia spirochetes. Asbrink E Acta Derm Venereol Suppl (Stockh); 1985; 118():1-63. PubMed ID: 3901647 [TBL] [Abstract][Full Text] [Related]
13. [Etiology of erythema migrans disease and Lyme disease. Review and results of personal study]. Neubert U Hautarzt; 1984 Nov; 35(11):563-70. PubMed ID: 6519987 [TBL] [Abstract][Full Text] [Related]
14. Changes in Borrelia burgdorferi-specific serum IgG antibody levels in patients treated for acrodermatitis chronica atrophicans. Olsson I; Asbrink E; von Stedingk M; von Stedingk LV Acta Derm Venereol; 1994 Nov; 74(6):424-8. PubMed ID: 7701871 [TBL] [Abstract][Full Text] [Related]
15. Long-term prognosis in patients treated for erythema chronicum migrans and acrodermatitis chronica atrophicans. Hulshof MM; Vandenbroucke JP; Nohlmans LM; Spanjaard L; Bavinck JN; Dijkmans BA Arch Dermatol; 1997 Jan; 133(1):33-7. PubMed ID: 9006370 [TBL] [Abstract][Full Text] [Related]
16. [The spirochetal etiology of erythema chronicum migrans and of meningo-polyneuritis Garin-Bujadoux-Bannwarth]. Ackermann R Z Hautkr; 1983 Nov; 58(22):1616, 1619-21. PubMed ID: 6659638 [TBL] [Abstract][Full Text] [Related]
17. Detection of serum antibodies against Borrelia burgdorferi with some commercially available serological tests. Melby K; Steinbakk M; Jensenius M; Figenschau KJ NIPH Ann; 1990 Dec; 13(2):37-44. PubMed ID: 2093855 [TBL] [Abstract][Full Text] [Related]
18. [Erythema migrans borreliosis in the Federal Republic of Germany. Epidemiology and clinical aspects]. Schmidt R; Kabatzki J; Hartung S; Ackermann R Dtsch Med Wochenschr; 1985 Nov; 110(47):1803-7. PubMed ID: 3905325 [TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients. Glatz M; Golestani M; Kerl H; Müllegger RR Arch Dermatol; 2006 Jul; 142(7):862-8. PubMed ID: 16847202 [TBL] [Abstract][Full Text] [Related]
20. Differential expression of cytokine mRNA in skin specimens from patients with erythema migrans or acrodermatitis chronica atrophicans. Müllegger RR; McHugh G; Ruthazer R; Binder B; Kerl H; Steere AC J Invest Dermatol; 2000 Dec; 115(6):1115-23. PubMed ID: 11121150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]